Afzal Aasim, Hall Shelley A
Division of Cardiology, Department of Internal Medicine, Baylor University Medical CenterDallas Texas.
Center for Advanced Heart and Lung Disease, Baylor University Medical CenterDallas Texas.
Proc (Bayl Univ Med Cent). 2018 Aug 27;31(4):453-456. doi: 10.1080/08998280.2018.1470853. eCollection 2018 Oct.
Temporary mechanical cardiac support (TMCS) devices intend to restore systemic perfusion and prevent further end-organ damage in patients with refractory cardiogenic shock until the insult is addressed. TMCS has been associated with reductions in hospital costs and in-hospital mortality. We review the four primary TMCS modalities available: intra-aortic balloon pump, TandemHeart, veno-arterial extracorporeal membrane oxygenation, and Impella pump. All have their own implantation technique and hemodynamic profile, and their use may therefore be tailored to the specific patient's needs. The appropriate TMCS may thus help stabilize the patient, enabling the care team to make decisions about durable support or transplantation.
临时机械性心脏支持（TMCS）设备旨在恢复难治性心源性休克患者的全身灌注并防止进一步的终末器官损伤，直至解决病因。TMCS与降低医院成本和住院死亡率相关。我们回顾了现有的四种主要TMCS模式：主动脉内球囊反搏、TandemHeart、静脉-动脉体外膜肺氧合和Impella泵。所有这些模式都有各自的植入技术和血流动力学特征，因此其使用可根据特定患者的需求进行调整。因此，合适的TMCS可能有助于稳定患者病情，使护理团队能够就长期支持或移植做出决策。
